Association between the triglyceride glucose index and atherosclerotic cardiovascular disease in the general population: analysis of the national health and nutrition examination survey 1999-2004

被引:3
作者
Sun, Jihong [1 ]
Chen, Xiaojie [1 ]
Lu, He [2 ]
Zhao, Yifan [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou, Henan, Peoples R China
[2] Peoples Hosp Jiawang Dist Xuzhou, Dept Radiol, Xuzhou, Jiangsu, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
triglyceride-glucose index; atherosclerotic cardiovascular disease; coronary artery disease; ischemic stroke; peripheral arterial disease; PERIPHERAL ARTERIAL-DISEASE; INSULIN-RESISTANCE; TYG INDEX; OUTCOMES; YOUNG; RISK; ABPI;
D O I
10.3389/fendo.2024.1376357
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The triglyceride-glucose (TyG) index, a reliable substitute indicator of insulin resistance (IR), is considered an independent risk factor for long-term outcomes in patients with cardiovascular disease. However, studies investigating the association between TyG and atherosclerotic cardiovascular disease (ASCVD) are limited and lack direct evidence. We aim to examine the relationship between the TyG index and ASCVD through a comprehensive cross-sectional study. Methods Overall, 7212 participants from the 1999-2004 National Health and Nutrition Examination Survey were included. The baseline TyG index was calculated as ln [fasting triglyceride (mg/dL) x fasting blood glucose (mg/dL)/2]. Restricted cubic spline (RCS) regression, univariate logistic regression, and multivariate logistic regression analysis were used to evaluate the association between the TyG index and ASCVD. Results In the overall population, a multivariate logistic regression analysis showed that the TyG level was not only positively associated with ASCVD [OR (95%CI): 1.29 (1.01,1.64), P=0.042], coronary artery disease (CAD) [OR (95%CI): 1.82(1.33,2.48), P<0.001], and stroke [OR (95%CI): 2.68(1.54,4.69), P=0.002], but also linearly correlated with all three (P-overall<0.001; P-non-linear >0.05). Although the TyG index was not associated with peripheral arterial disease (PAD) [OR (95%CI): 1.00 (0.73,1.36), P>0.900], it showed a U-shaped correlation with PAD (P-overall <0.001; P-non-linear= 0.0085), and the risk of PAD was minimized when TyG=8.67. By incorporating the TyG index into the baseline risk model, the accuracy of ASCVD prediction was improved [AUC: baseline risk model, 0.7183 vs. baseline risk model + TyG index, 0.7203, P for comparison=0.034]. The results of the subgroup analysis were consistent with those of the main analysis. Conclusion The TyG index was independently associated with ASCVD, CAD, and stroke, suggesting that it may serve as a valid indicator for predicting ASCVD in the entire population.
引用
收藏
页数:13
相关论文
共 54 条
[1]  
Al-Qaisi M, 2009, VASC HEALTH RISK MAN, V5, P833
[2]   Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients [J].
Alizargar, Javad ;
Bai, Chyi-Huey ;
Hsieh, Nan-Chen ;
Wu, Shu-Fang Vivienne .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[3]   Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents [J].
Allard, P ;
Delvin, EE ;
Paradis, G ;
Hanley, JA ;
O'Loughlin, J ;
Lavallée, C ;
Levy, E ;
Lambert, M .
CLINICAL CHEMISTRY, 2003, 49 (04) :644-649
[4]   The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study [J].
Barzegar, Niloofar ;
Tohidi, Maryam ;
Hasheminia, Mitra ;
Azizi, Fereidoun ;
Hadaegh, Farzad .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[5]   The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithmof the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort [J].
Blaum, Christopher ;
Seiffert, Moritz ;
Gossling, Alina ;
Kroeger, Friederike ;
Bay, Benjamin ;
Lorenz, Thiess ;
Braetz, Julian ;
Graef, Annika ;
Zeller, Tanja ;
Schnabel, Renate ;
Clemmensen, Peter ;
Westermann, Dirk ;
Blankenberg, Stefan ;
Brunner, Fabian J. ;
Waldeyer, Christoph .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) :47-56
[6]   The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity [J].
Boren, Jan ;
Williams, Kevin Jon .
CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (05) :473-483
[7]   Insulin Resistance, Hyperglycemia, and Atherosclerosis [J].
Bornfeldt, Karin E. ;
Tabas, Ira .
CELL METABOLISM, 2011, 14 (05) :575-585
[8]   Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study [J].
Chen, G. ;
Shi, L. ;
Cai, L. ;
Lin, W. ;
Huang, H. ;
Liang, J. ;
Li, L. ;
Lin, L. ;
Tang, K. ;
Chen, L. ;
Lu, J. ;
Bi, Y. ;
Wang, W. ;
Ning, G. ;
Wen, J. .
HORMONE AND METABOLIC RESEARCH, 2017, 49 (02) :135-141
[9]   Associations of serum amino acids with insulin resistance among people with and without overweight or obesity: A prospective study in Japan [J].
Chen, Sanmei ;
Miki, Takako ;
Fukunaga, Ami ;
Eguchi, Masafumi ;
Kochi, Takeshi ;
Nanri, Akiko ;
Kabe, Isamu ;
Mizoue, Tetsuya .
CLINICAL NUTRITION, 2022, 41 (08) :1827-1833
[10]   Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease [J].
Colantonio, Lisandro D. ;
Hubbard, Demetria ;
Monda, Keri L. ;
Mues, Katherine E. ;
Huang, Lei ;
Dai, Yuling ;
Jackson, Elizabeth A. ;
Brown, Todd M. ;
Rosenson, Robert S. ;
Woodward, Mark ;
Muntner, Paul ;
Farkouh, Michael E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) :251-264